Science Blockchain Releases Q1 2018 SCI Token NAV

Santa Monica, CA — April 2, 2018 — Science Blockchain Pte Ltd., the premier startup development firm investing in blockchain technology companies, today announces that the NAV of each SCI token as of March 31, 2018, is $0.74, based on the NAV of the underlying VC fund, Science Blockchain Holdings, LP. Overall market conditions in cryptocurrency have led to a small decrease.

The Science Blockchain portfolio includes the following investments:

• Bitcoin / BTC
• Ether / ETH
• Blockchain Delta
• WePower tokens / WPR
• SpringRole tokens / SPRMT
• PolySwarm tokens / NCT
• Splyt (future tokens)
• Teal Aura (equity)

None of the recently announced partnerships or incubations including SpringRole, 8base and Signix have completed a subsequent financing yet, so Science Blockchain is still carrying each of those investments at cost. Once the offerings are complete, they will be reflected at market price.

Splyt is a new venture we are incubating, and we’ll share details on it soon. Teal Aura is part of the same incubation.

The Science Blockchain team appreciates the trust and support of the SCI token holders and is committed to earning that trust each day through executing on its investment strategy.

All SCI investors should have received an email detailing the withdrawal procedures. As a reminder, US investors’ tokens are locked for one year and not able to be withdrawn from tokenhub. SCI Tokens were made available for withdrawal by non-US investors from TokenHub beginning on Dec 14, 2017. Withdrawal requests could be made starting at 06:00 pm PT Dec 13, 2017. Withdrawal requests made before 08:00 am PT Dec 14, 2017 were fulfilled before 23:59 (11:59 pm) PT on Dec 14, 2017. All subsequent requests will be processed on a daily basis on U.S. business days and may take up to 2 business days to process due to security precautions.

To find information on the contract, you can visit: https://etherscan.io/token/0x1556a3ddb4fa2e9e8d6355380e4d22f9d32592cc

SCI Token holders are encouraged to register and visit https://www.science-inc.com/blockchain.html for current information or to contact the team and join Science Blockchain’s Telegram community (https://t.me/ScienceBlockchain) for investment discussions.

About Science Blockchain

Science has been helping entrepreneurs build successful businesses for more than six years, during which time it has funded or founded more than 85 companies, and has had $1.3B in aggregate portfolio company exits. Science Blockchain, the first incubator in the world to be funded by its own tokenized compliant securities offering (token: SCI), intends to continue this history of successful company building by helping incredible blockchain entrepreneurs create and scale the software giants of the next century. We do this in three primary ways: 1) incubating promising early stage blockchain ventures, 2) engaging on a very limited and selective basis, with companies looking to take advantage of the possibilities presented by tokenized economies, and 3) investing in compliant private offerings of blockchain businesses. The unique token structure of SCI allows us to distribute 70% of the total tokens that Science Blockchain receives through our incubation and investment strategies directly to the SCI token holders. For more details, please visit https://www.science-inc.com/blockchain.html.

Disclaimer: This document contains certain forward-looking statements, relating to Science Inc.’s business, which can be identified by the use of forward-looking terminology such as “promising”, “plans”, “anticipated”, “will”, “project”, “believe”, “forecast”, “expected”, “estimated”, “targeting”, “aiming”, “set to”, “potential”, “seeking to”, “goal”, “could provide”, “intends”, “is being developed”, “could be”, “on track”, or similar expressions, or by express or implied discussions regarding potential filings or marketing approvals, or potential future sales of product candidates. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. Science Inc. is providing this information as of the date of this document and does not assume any obligation to update any forward-looking statements contained in this document as a result of new information, future events or developments or otherwise.